NASDAQ:COSM Cosmos Health Q4 2024 Earnings Report $0.32 +0.02 (+7.26%) Closing price 09/18/2026 04:00 PM EasternExtended Trading$0.32 +0.01 (+1.64%) As of 09/18/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Cosmos Health EPS ResultsActual EPS-$0.08Consensus EPS -$0.09Beat/MissBeat by +$0.01One Year Ago EPSN/ACosmos Health Revenue ResultsActual Revenue$14.22 millionExpected Revenue$14.50 millionBeat/MissMissed by -$280.00 thousandYoY Revenue GrowthN/ACosmos Health Announcement DetailsQuarterQ4 2024Date4/15/2025TimeDuring Market HoursConference Call DateN/AConference Call TimeN/AUpcoming EarningsCosmos Health's next earnings date is estimated for Friday, November 13, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Cosmos Health Earnings HeadlinesCosmos Health Inc.: Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management MarketSeptember 14, 2026 | finanznachrichten.deCosmos Health Unit Enters 5-Year Contract Manufacturing Deal With Viofar Over Cardiovascular MedicineSeptember 11, 2026 | finance.yahoo.comPorter flew 3,300 miles to investigate this systemPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.September 20 at 1:00 AM | Porter & Company (Ad)Cosmos Health Inc.: Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million ...September 11, 2026 | finanznachrichten.deCOSM Again Expands its Market and Accelerates its GrowthSeptember 10, 2026 | msn.comCosmos Health Inc.: Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health MarketSeptember 9, 2026 | finanznachrichten.deSee More Cosmos Health Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Cosmos Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cosmos Health and other key companies, straight to your email. Email Address About Cosmos HealthCosmos Health (NASDAQ:COSM) is a global healthcare group focused on pharmaceuticals, nutraceuticals and healthcare-related services. The company develops, manufactures and distributes branded and generic pharmaceutical products, over-the-counter medicines, medical devices and nutritional supplements through its subsidiaries and commercial partners. Cosmos Health’s portfolio includes Sky Premium Life, a line of premium nutritional supplements, as well as pharmaceutical manufacturing operations associated with Cana Laboratories in Greece. Its businesses serve customers and distribution channels in markets including Europe, the United Kingdom, Greece and the United States, although product availability varies by geography and regulatory requirements. Founded in 2009, Cosmos Health has expanded through the development of its own healthcare brands and acquisitions in the pharmaceutical and healthcare sectors. The company is led by Greg Siokos, who serves as chief executive officer and has been associated with the company since its founding.View Cosmos Health ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles J.B. Hunt's Stock Plunges After Market Misprices Profit WarningLennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. HousingThese 3 Stocks Sit at the Center of NVIDIA’s Cybersecurity PushGold Has Gone Sideways, But These 3 Stocks Haven’tLennar's Q3 Miss Hides a Stronger Operating Story Beneath the Housing SlumpAeluma’s Selloff Could Be Setting Up Its Next Big MoveBraze Beat Expectations—Now 2 SaaS Peers Are in Focus Upcoming Earnings Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
